Preface: Malignant syndrome in Parkinson's disease.
Narabayashi
H
H
Department of Neurology, Juntendo University School of Medicine, 2-1-1 Hongo Bunkyo, Tokyo 113-8421, Japan.
Mizuno
Y
Y
D000978:Antiparkinson Agents / Q000009:adverse effects*; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D010300:Parkinson Disease / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome
D000978:Antiparkinson Agents